Showing results (41-50 of 61) with videos related to
Sort By:
Pageof 7
Gastroenterology|March 28, 2026
A Randomized Double-Blind, Placebo-Controlled Dose-Response Study to Assess the Gluten Threshold Dose in Celiac DiseaseA James M Daveson, Emma Craig, Alina Vitak, et al.Ebiomedicine|December 2, 2017
Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 StudyA James M Daveson, Hooi C Ee, Jane M Andrews, et al.Journal of Gastroenterology and Hepatology|November 11, 2024
Celiac disease care differs significantly between high- and low-middle-income countries: a global survey of celiac experts from 63 countriesSamagra Agarwal, Shubham Prasad, Ashish Agarwal, et al.Gastroenterology|July 31, 2015
Consistency in polyclonal T-cell responses to gluten between children and adults with celiac diseaseMelinda Y Hardy, Adam Girardin, Catherine Pizzey, et al.Alimentary Pharmacology & Therapeutics|September 5, 2019
Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac diseaseJason A Tye-Din, A James M Daveson, Hooi C Ee, et al.Science Advances|February 13, 2019
Standards for distribution models in biodiversity assessmentsMiguel B Araújo, Robert P Anderson, A Márcia Barbosa, et al.United European Gastroenterology Journal|March 28, 2020
Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivityJason A Tye-Din, Gry I Skodje, Vikas K Sarna, et al.The Lancet. Gastroenterology & Hepatology|March 10, 2023
Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 studyJason A Tye-Din, A James M Daveson, Gautam Goel, et al.The American Journal of Gastroenterology|November 19, 2021
Plasma IL-2 and Symptoms Response after Acute Gluten Exposure in Subjects With Celiac Disease or Nonceliac Gluten SensitivityAmanda K Cartee, Rok Seon Choung, Katherine S King, et al.Immunity|July 17, 2007
A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac diseaseKate N Henderson, Jason A Tye-Din, Hugh H Reid, et al.Pageof 7